China's Guilin Sanjin Pharmaceutical Co and Zhejiang Wanma Cable Co on Thursday said they would list shares on the Shenzhen Stock Exchange on Friday, the first two initial public equity offerings in the Chinese stock market since last September.
Guilin Sanjin, a traditional Chinese medicine maker, raised 910 million yuan ($133 million) in an IPO on June 29 to fund technical upgrades and product development, it said in a statement published in the official Securities Times.
Industrial cable maker Zhejiang Wanma 002276.SZ said in a separate statement that it raised 575 million yuan in an IPO on July 2 to fund two cable projects and supplement working capital.
They will become the first two companies to list in China after Jiangsu Huachang Chemical Co made its trading debut last September. China then quietly suspended IPOs because of the slumping stock market at the time.
But since the start of this year, China's benchmark SSE Composite stock index .SSEC has jumped more than 60 percent, pushing regulators to resume IPOs, partly in an effort to help cool a potentially overheating market.
Hong Kong-listed toll road operator Sichuan Expressway Co on Monday said it planned to raise up to 2 billion yuan in a public sale of new shares on the Shanghai Stock Exchange in mid-July to become China's first major IPO since last September.
State media on Wednesday said China State Construction Engineering Corp, the country's largest homebuilder, would raise as much as 42.6 billion yuan in a Shanghai IPO next month.
(Reporting by Lu Jianxin and Jacqueline Wong)